Academic Journal
© 2008 Canadian Medical Association or its licensors
| العنوان: | © 2008 Canadian Medical Association or its licensors |
|---|---|
| المؤلفون: | Joel Lexchin, Msc Md, Juurlink Dn, Park-wyllie Ly, Kapral Mk. The Effect |
| المساهمون: | The Pennsylvania State University CiteSeerX Archives |
| المصدر: | http://www.cmaj.ca/content/178/6/730.2.full.pdf. |
| سنة النشر: | 2008 |
| المجموعة: | CiteSeerX |
| مصطلحات موضوعية: | Squibb Canada, 2005 Dec 19. Available, www.hc-sc |
| الوصف: | Information about a discontinued drug In their research letter on the extent to which publication in the biomedical lit-erature concerning drug-induced harm can influence the legal process, David Juurlink and colleagues mention that the manufacturer of gatifloxacin stopped marketing the drug worldwide on May 1, 2006.1 Health Canada issued a number of alerts about the potential for this product to interfere with glu-cose metabolism2,3 but never bothered to formally inform either the public or health care professionals that oral and intravenous forms of this drug were withdrawn from sale in Canada. The only place where one can find this in-formation is by searching the discon-tinued products in Health Canada’s |
| نوع الوثيقة: | text |
| وصف الملف: | application/pdf |
| اللغة: | English |
| Relation: | http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.527.9162; http://www.cmaj.ca/content/178/6/730.2.full.pdf |
| الاتاحة: | http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.527.9162 http://www.cmaj.ca/content/178/6/730.2.full.pdf |
| Rights: | Metadata may be used without restrictions as long as the oai identifier remains attached to it. |
| رقم الانضمام: | edsbas.A9A02404 |
| قاعدة البيانات: | BASE |
| الوصف غير متاح. |